GlassScriptPhysician profile
Rekha Hamal
NPI 1225227176
$269.19
in general payments reported to CMS, 2019-2025
8 companies · $52.32 in 2025
The $52.32 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.89 · 2020: $12.47 · 2021: $45.00 · 2022: $14.66 · 2023: $13.24 · 2024: $34.61 · 2025: $52.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $82.09 | 2019-2023 | Immunocap |
| Merck Sharp & Dohme LLC | $45.30 | 2021-2024 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $42.70 | 2019-2022 | |
| Exact Sciences Corporation | $30.37 | 2025 | Cologuard Collection Kit |
| Cranial Technologies, INC | $21.95 | 2025 | Doc Band |
| Lilly USA, LLC | $19.31 | 2024 | Mounjaro, Zepbound |
| Pfizer INC. | $15.00 | 2021 | |
| Amarin Pharma, INC. | $12.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rekha Hamal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.